Contributed by NAMPA / AFP.
Press Release from Business Wire : Banyan Biomarkers, Inc.
ATTENTION - Usable ///
SAN DIEGO, Feb 14, 2018 (BSW) - Banyan
Biomarkers, Inc., a pioneer in developing biomarkers for traumatic
brain injury (TBI), today announced that the U.S. Food and Drug
Administration (FDA) has granted the De Novo request for the
commercialization of Banyan BTITM (Brain Trauma Indicator),
an in vitro diagnostic blood test to aid in the evaluation of patients
with suspected TB ...